Related Experiment Video

Updated: Jun 1, 2026

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
09:20

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

Published on: May 4, 2021

[Adiponectin decreases insulin receptor substrate-1 phosphorylation in the liver of OLETF rats possibly through

Bo Zhu1, Chen-zhong Li, Yi Qian

  • 1Department of Endocrinology and Metabolism, Southern Medical University, Guangzhou , China. bozhudr@gmail.com

Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University
|May 24, 2011
PubMed
Abstract

Insights

Adiponectin (APN) deficiency in OLETF rats is linked to impaired insulin signaling and elevated lipids. APN may inhibit the insulin pathway via the IKK/NFκB pathway, contributing to type 2 diabetes.

Area of Science:

  • Metabolic disease research
  • Endocrinology
  • Molecular biology

Context:

  • Obesity and Type 2 Diabetes Mellitus (T2DM) are significant global health concerns.
  • Insulin resistance is a key feature of T2DM, involving complex molecular pathways.
  • Adiponectin (APN), an adipokine, plays a crucial role in glucose and lipid metabolism.

Purpose:

  • To investigate the effect of adiponectin (APN) on the hepatic insulin signaling pathway in Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
  • To elucidate the molecular mechanism by which APN influences insulin signaling and contributes to metabolic dysfunction.

Summary:

  • Lower plasma adiponectin levels were observed in OLETF rats compared to LETO rats from 8 weeks of age.
  • OLETF rats exhibited increased blood lipid levels and altered hepatic levels of APN, phosphotyrosine of insulin receptor substrate-1 (p-IRS-1), IKKβ, and nuclear-κB (NF-κB) at 32 weeks.
  • Adiponectin levels correlated inversely with blood lipids and positively with p-IRS-1 and NF-κB levels in OLETF rats.

Impact:

  • Findings suggest APN may inhibit the hepatic insulin signaling pathway by decreasing IRS-1 tyrosine phosphorylation via the IKK/NFκB pathway.
  • This inhibition contributes to the development of hyperlipidemia, hyperglycemia, and type 2 diabetes in OLETF rats.
  • Understanding this mechanism could inform therapeutic strategies for metabolic diseases.

More Related Videos

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance09:48

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance

Published on: February 17, 2023

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.